Bromfenac Generic Name & Formulations
Bromfenac 0.09%, oph soln; contains benzalkonium chloride, sulfites.
Post-operative inflammation and reduction of ocular pain following cataract extraction.
Bromfenac Dosage and Administration
≥18yrs: 1 drop in affected eye(s) once daily starting 1 day before surgery, continued on day of surgery, and for 14 days post-op. May be given with other topical ophthalmics (eg, alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, mydriatics); administer at least 5 minutes apart.
<18yrs: not recommended.
Bromfenac Boxed Warnings
Bleeding tendencies. May slow or delay wound healing. Complicated/repeat ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Rheumatoid arthritis. Diabetes. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Risk of corneal adverse events may be increased if used >24hrs before surgery, or beyond 14-days post-op. Contact lenses (remove during therapy). Pregnancy (Cat.C; avoid during late pregnancy). Nursing mothers.
Concomitant topical corticosteroids may potentiate healing problems. Caution with concomitant drugs that prolong bleeding time.
Bromfenac Adverse Reactions
Ocular effects (eg, abnormal sensation, conjunctival hyperemia, burning, stinging, pain, pruritus, redness, iritis), headache; keratitis, corneal reactions (eg, epithelial breakdown, thinning, erosion, ulceration/perforation).
Bromfenac Clinical Trials
Formerly known under the brand name Bromday.
Bromfenac Patient Counseling